Spitzoid neoplasms are classifi ed as Spitz naevi, atypical Spitz tumours and spitzoid melanomas. In 10-15% of these lesions, anaplastic lymphoma kinase (ALK) fusions were identifi ed, that can be demonstrated by immunohistochemical tests.
Introduction
Spitzoid melanoma (SM) belongs to the group of melanocytic lesions with spitzoid features, along with Spitz nevus (SN) and atypical spitzoid tumor (AST). Spitzoid melanocytic tumors have considerable morphologic and molecular differences from the other melanocytic lesions (1, 2) . In some cases, prediction of biologic behavior and metastatic risk evaluation may be very diffi cult.
Recent studies report the presence of kinase fusions within this class of neoplasm, efforts being made to identify new markers with prognostic signifi cance in these melanocytic tumors (3) (4) (5) . Rearrangement of receptor tyrosine kinases like anaplastic lymphoma kinase (ALK), ROS1, neurotrophic tyrosine kinase receptor type 1 (NTRK1), hepatocyte growth factor receptor (MET), RET, and serine-threonine kinase BRAF are identifi ed in almost half of all Spitzoid tumours (6) .
Case report
A 15-year-old girl presented a polypoid pigmented nodule on her left thigh. The lesion was present at least two years prior to excision but grew signifi cantly in the last few months.
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Low power microscopic examination revealed a melanocytic proliferation arranged in sheets, nests and trabeculi involving mostly the dermis (Figures 1 & 2) . At higher magnifi cation, a minor jonctional component (consisting in small nests and isolated cells with predominant basal location, without pagetoid spread) was identifi ed. In the deeper areas, tumor proliferation consists mainly in small trabeculi dissecting dermal components with focal arrangement in small nodules in perivascular and/or periadnexal location in deep dermis. The maximum thickness of the tumor was 13 mm. Tumor growth extended up to 1.8 mm from the deepest resection margin and 0.5 mm from the closest lateral resection margin. Most of the tumor cells were large, epithelioid, with abundant cytoplasm, vesicular nuclei, prominent eosinophilic nucleoli and occasional intranuclear inclusions ( Figures 3 & 4) (spitzoid phenotype); a second population of smaller cells with hypercromatic nuclei and/or clear almost foamy cytoplasm was identifi ed; prominent nuclear pleomorphism with numerous giant tumor cells dispersed in the whole thickness of the tumor was present (Fig. 5) ; no obvious decrease of the dimensions of tumor cells in the deeper parts of the tumor was recor ded (absence of maturation); variable pigmentation HEx100. Thin epidermis with rare atypical solitary melanocytes at the junc on; compact dermal prolifera on of highly atypical epithelioid melanocytes, with focal intercellular discohesivity; some cells with monstrous nucleus are intermingled Case presentation HEx400. Marked cyto-nuclear pleomorphism with frequent mul nucleated and monstrous cells *proteinase K digestion of paraffi n section 37o C for 10 min **high temperature antigen retrieval using 0.01 M citrate retrieval solution pH 6 for 15 min **high temperature antigen retrieval using EDTA retrieval solution pH 8 for 15 min
The tumor showed mild to moderate lymphocytic infl ammatory infi ltrate with relatively frequent melanophages and focal desmoplasia.
Immunohistochemical tests for S100 protein, HMB45, T311, Melan A, p16, p21, Ki67, ALK were performed using specifi c autoantibodies and Novolink Max DAB (Polymer, Leica, Nussloch, Germany) (for specifi c details of primary antibodies, see Table 1 ). S100 protein was diffuse positive. Melan A immunohistochemical stain confi rmed melanocytic origin (Fig. 6); HMB45 (Fig. 7) and T311 (Fig. 8 ) markers stained numerous cells unevenly distributed within the whole tumor mass, including the deepest parts, without signs of maturation. p16 was negative (Fig. 9 ) and p21 positive in tumor cells (Fig. 10) . Ki67 was positive in few tumor cell nuclei (Ki67 index 1-5%) (Fig. 11) . The tumor cells were negative for ALK (Fig. 12) .
The lesion was diagnosed as nodular melanoma with spitzoid features, with reticular dermis invasion (Clark IV), with a 13 mm Breslow index and with one mitotic fi gure/1 mm 2 .
Sentinel lymph node biopsy was performed in the same surgical session with local re-excision, two months after primary tumor resection; no recurrent tumor was identifi ed within the surgical scar; four lymph nodes were resected, three of them showing metastases. No other metastases were identifi ed by CT scan elsewhere.
The patient is alive and well, free of disease, 20 months after primary tumor resection.
Discussion
Spitzoid melanoma (SM) is a rare tumor. It represents a melanoma characterized by some traits specifi c for Spitz nevus. To emphasize this matter, some authors prefer the term melanoma with Spitz nevus-like features (7) (8) (9) . Practically, SM represents a melanocytic proliferation that at fi rst sight appears much like a Spitz nevus, but at closer view shows traits of malignancy. The majority of SM are diagnosed in adult age, although some occur in adolescents and prepubertal children (9, 10) . Head, neck and limbs represent the most common location, but SM can be considered to have a ubiquitous occurrence (11) (12); most often, it appears as an amelanotic nodule, less often pigmented with variegated color; it may reach over 1 cm in size and sometimes ulcerates (9, 13, 14) . There are evidences that SMs have a better prognosis, with a lower risk of tumor recurrence and metastasis than other types of melanomas (14) .
Efforts were made to formulate some histopathological diagnostic criteria for SM; unfortunately, in some cases, they turn out to be insuffi cient (15-17):
1. Thick/ deep lesion -A spitzoid lesion broader than 10 mm or a lesion that reaches hypodermis should be suspected of malignancy.
2. Dermal architecture in solid sheets -SM shows a dermal arrangement in large nests, with a tendency to confl uence and sheets formation; identifi cation of large nests in the base of the tumor also supports the diagnosis of melanoma.
3. Tumoral nodules with expansive growth pattern -There are often nodules of tumoral melanocytes that are considerably larger than the adjoining nests; these nodules often show a more marked cytonuclear atypia.
4. High mitotic rate pleads for malignancy, but the statement is debatable. In a specifi c morphological background, with architectural and cytologic marked atypia, even the fi nding of an isolated mitotic fi gure favors the diagnosis melanoma. Pediatric patients with Spitz nevi, especially those younger than 10 years old, can have some mitoses, even near the deepest part of the lesion; this fi nding in this specifi c group of patients will not be considered an unconditional malignancy trait; on the other hand, in adult patients, mitoses in the profound tumoral front provide a hint for SM diagnosis. The presence of clusters of mitotic fi gures also favour the diagnosis of melanoma.
5. Cellular pleomorphism -The cellular morphology of a SM resembles that of a Spitz nevus, but the nuclei have higher pleomorphism. An important clue for diagnosis of SM is the abrupt change of cells morphology at the same level of the tumor (absence of side-to side maturation).
6. Individual cell necrosis -The presence of individual necrotic cells or nuclear debris favors malignancy. Necrosis can be seen in a Spitz nevus in the context of posttraumatic changes.
7. High cellular density -The presence of a high cellularity on a high-power fi eld points towards a diagnosis of melanoma.
8. Cytological change -Cytologic alterations such as marked pleomorphism, coarse chromatin, and proeminent eosinophilic nucleoli are not characteristic to the majority of cells in most Spitz nevi and defi nitely should not be identifi ed in the lower part of any Spitz nevus. Nucleoli as large as half of the nucleus or multiple large nucleoli are typically found in melanoma. Cytoplasm of SM cells is scant, vacuolated, with dusty melanin. Cell contours are irregular, vague.
9. Uneven distribution of the pigment or presence of pigment in the deep portion of the lesion is also a trait that suggests malignancy.
10. Signs of solar elastosis -The diagnosis of Spitz nevus must be made with caution in sun-damaged skin. However, many SM developed without signs of solar elastosis.
11. Absence of zonation -Absence of homogeneous cytological and architectural traits at the distinct horizontal levels is a suggestion of melanoma; also, nuclear pleomorphism in restricted areas of the lesion should be interpreted with caution.
12. Absence of cell maturation -Cells become smaller in profound dermis in a Spitz nevus, whereas in melanoma this aspect can be absent. The identifi cation of large nests in the base of the tumor supports melanoma.
13. Consumption of the epidermis -Thinning of the epidermis can be seen in both SM and Spitz nevus. However, in Spitz nevus, epidermis consumption is restricted to limited areas; in SM, this phenomenon is more frequent.
14. High Ki-67 rate -Ki-67-positive cells comprise about 2-3% of the population in Spitz nevus, and more then 5-10% in melanoma. Moreover, Ki-67-positive cells are usually present in the base of the melanocytic lesion in melanoma, while in Spitz nevus they are found in the superior half of the lesion.
In our case, the diagnosis was made on morphologic and immunohistochemical features. The peculiar aspect of the tumor, with spitzoid areas and limited areas vaguely resembling blue nevus, raised problems of differential diagnosis. Also, patient location and age represented arguments in favor of a less aggressive biologic behaviour. The dimension of the tumor, the prominent pleomorphism, the presence of satellites and vascular emboli oriented the diagnosis towards malignancy.
Tumor presence in regional lymph nodes (further established by sentinel lymph node biopsy) favors the diagnosis of malignancy; however, tumor implants in regional lymph nodes in spitzoid tumor is still a matter of debate, its biologic signifi cance being unclear -all patients with such a lesion (spitzoid tumors and tumor "metastases" in regional lymph nodes) being alive, free of evidence of disease, with a medium follow-up period of 57-72 months (15, 17) . In our case, the patient's evolution -two years free of disease, despite the involvement of several lymph nodes -speaks in favor of tumor implant within lymph node, and not metastasis.
Patients with fusion-positive Spitzoid neoplasm are younger than those diagnosed with tumors without translocations (5), a trait also shared by individuals with kinase fusions in other tumors -Patricia-Irina Stîngă, Alina Stoica, Mirela Daniela Cioplea, Sabina-Andrada Zurac, Luciana Nichita, Cristiana Gabriela Popp, Alexandra Ioana Cioroianu, Alexandra Eugenia Bastian lung cancers, thyroid cancers, or central nervous system tumors (18) (19) (20) . ALK was fi rst identifi ed as the protein product of an abnormal fusion gene produced by a specifi c chromosomal translocation in anaplastic large cell lymphoma (21) . Later, it was identifi ed in other neoplasms, either benign or malignant, such as lung adenocarcinoma, Ewing sarcoma, infl ammatory myofbroblastic tumor, epithelioid fi brous histiocytomas (22) . ALK was also detected in approximately 10-15% of all spitzoid tumors; ALK fusions are found in benign Spitz naevi, atypical Spitz tumors, and less commonly in spitzoid melanoma (23) (24) (25) (26) . Immunohistochemistry is widely considered a good surrogate for ALK rearrangement (5, 27) . There are evidences that spitzoid melanocytic tumors with ALK imunoreactivity have specifi c histopathological features (25, 26, 28) . In a previous study, we analyzed several spitzoid tumors for ALK expression. None of our cases of melanoma (3 SM -present case included -from a total of 33 spitzoid tumors) was positive; moreover, a phenotype of the ALK positive spitzoid tumor patient emerged: young female with large tumor (over 8 mm in the largest diameter) on trunk with both junctional and dermal component and plexiform dermal architecture (29) .
To date, no histopathological diagnostic criteria have been formulated and proved to establish the diagnostic with certainty to anticipate an aggressive course for a spitzoid tumor. Consequently, there is an imperative need to study these tumors, to refi ne the existing diagnostic criteria and fi nd new ones to facilitate a better diagnosis. 
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